Connection

MUHAMMAD SOHAIL to Aged

This is a "connection" page, showing publications MUHAMMAD SOHAIL has written about Aged.
Connection Strength

1.618
  1. Clinical Determinants of Frailty in End-stage Renal Disease. J Coll Physicians Surg Pak. 2022 Nov; 32(11):1506-1508.
    View in: PubMed
    Score: 0.059
  2. Etiology, clinical characteristics, and outcome of infective endocarditis: 10-year experience from a tertiary care center in Pakistan. Monaldi Arch Chest Dis. 2022 Mar 28; 92(4).
    View in: PubMed
    Score: 0.057
  3. Staphylococcus simulans bloodstream infection following CIED extraction. BMJ Case Rep. 2021 May 27; 14(5).
    View in: PubMed
    Score: 0.053
  4. Lawsonella clevelandensis: an emerging cause of vascular graft infection. BMJ Case Rep. 2021 Feb 26; 14(2).
    View in: PubMed
    Score: 0.052
  5. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States. Mayo Clin Proc. 2020 05; 95(5):858-866.
    View in: PubMed
    Score: 0.048
  6. Laryngeal histoplasmosis in a kidney transplant recipient. Transpl Infect Dis. 2019 Aug; 21(4):e13102.
    View in: PubMed
    Score: 0.046
  7. Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. Mayo Clin Proc. 2019 07; 94(7):1268-1277.
    View in: PubMed
    Score: 0.046
  8. Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):735-740.
    View in: PubMed
    Score: 0.045
  9. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts. Infection. 2018 Aug; 46(4):555-558.
    View in: PubMed
    Score: 0.043
  10. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018 05; 41(5):495-503.
    View in: PubMed
    Score: 0.043
  11. Clinical Manifestations and Outcomes of Fluoroquinolone-Related Acute Interstitial Nephritis. Mayo Clin Proc. 2018 01; 93(1):25-31.
    View in: PubMed
    Score: 0.042
  12. Prevalence and antibiogram of methicillin resistant Staphylococcus aureus isolated from medical device-related infections; a retrospective study in Lahore, Pakistan. Rev Soc Bras Med Trop. 2017 Sep-Oct; 50(5):680-684.
    View in: PubMed
    Score: 0.041
  13. Postsurgical mediastinal aspergilloma masquerading as malignancy. BMJ Case Rep. 2017 Aug 07; 2017.
    View in: PubMed
    Score: 0.041
  14. Strategies to prevent infections associated with cardiovascular implantable electronic devices. Expert Rev Med Devices. 2017 May; 14(5):371-381.
    View in: PubMed
    Score: 0.040
  15. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 08; 9(8).
    View in: PubMed
    Score: 0.038
  16. Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia. Am J Med. 2016 Feb; 129(2):221.e11-20.
    View in: PubMed
    Score: 0.036
  17. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2015 Jul 01; 61(1):18-28.
    View in: PubMed
    Score: 0.035
  18. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol. 2015 Apr 01; 115(7):912-7.
    View in: PubMed
    Score: 0.034
  19. Acute renal failure associated with albendazole therapy in a patient with trichinosis. BMJ Case Rep. 2014 May 19; 2014.
    View in: PubMed
    Score: 0.033
  20. Frequency of albuminuria in diabetic patients presenting with macrovascular complications. J Ayub Med Coll Abbottabad. 2014 Apr-Jun; 26(2):149-52.
    View in: PubMed
    Score: 0.033
  21. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis?patients. Am J Kidney Dis. 2014 Jul; 64(1):104-10.
    View in: PubMed
    Score: 0.032
  22. Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol. 2014 Feb; 37(2):225-30.
    View in: PubMed
    Score: 0.031
  23. Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol. 2013 Nov 01; 112(9):1403-9.
    View in: PubMed
    Score: 0.031
  24. Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection. BMJ Case Rep. 2011 Nov 21; 2011.
    View in: PubMed
    Score: 0.028
  25. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011 Nov 14; 171(20):1821-8.
    View in: PubMed
    Score: 0.027
  26. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31(2):171-83.
    View in: PubMed
    Score: 0.026
  27. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94.
    View in: PubMed
    Score: 0.023
  28. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
    View in: PubMed
    Score: 0.021
  29. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007 Jul 15; 45(2):166-73.
    View in: PubMed
    Score: 0.020
  30. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 08; 49(18):1851-9.
    View in: PubMed
    Score: 0.020
  31. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006 Feb; 119(2):147-54.
    View in: PubMed
    Score: 0.018
  32. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005 Aug; 80(8):1011-5.
    View in: PubMed
    Score: 0.018
  33. Coccidioidomycosis of the male genital tract. J Urol. 2005 Jun; 173(6):1978-82.
    View in: PubMed
    Score: 0.018
  34. Health risks to air travelers. Infect Dis Clin North Am. 2005 Mar; 19(1):67-84.
    View in: PubMed
    Score: 0.017
  35. Hernia repair mesh-associated Mycobacterium goodii infection. J Clin Microbiol. 2004 Jun; 42(6):2858-60.
    View in: PubMed
    Score: 0.016
  36. Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection. Mayo Clin Proc. 2004 Apr; 79(4):578-9.
    View in: PubMed
    Score: 0.016
  37. A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project. Mayo Clin Proc. 2021 06; 96(6):1438-1445.
    View in: PubMed
    Score: 0.013
  38. Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteraemia?- A retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1503-1510.
    View in: PubMed
    Score: 0.013
  39. Putting the 'Eye' in Spirochaetes. Sex Transm Infect. 2021 05; 97(3):173.
    View in: PubMed
    Score: 0.013
  40. Microbiology of Implant-Based Breast Reconstruction Infections: A Systematic Review. Ann Plast Surg. 2020 08; 85(2):194-201.
    View in: PubMed
    Score: 0.013
  41. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 10; 42(10):1331-1339.
    View in: PubMed
    Score: 0.012
  42. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A?Population-Based Study. JACC Clin Electrophysiol. 2019 09; 5(9):1071-1080.
    View in: PubMed
    Score: 0.012
  43. Is a single set of negative blood cultures sufficient to ensure clearance of bloodstream infection in patients with Staphylococcus aureus bacteremia? The skip phenomenon. Infection. 2019 Dec; 47(6):1047-1053.
    View in: PubMed
    Score: 0.012
  44. Safety of in-hospital insertable cardiac monitor procedures performed outside the traditional settings: results from the Reveal LINQ in-office 2 international study. BMC Cardiovasc Disord. 2019 05 31; 19(1):132.
    View in: PubMed
    Score: 0.012
  45. Secondary bacterial peritonitis and pelvic abscess due to Clostridium difficile. BMJ Case Rep. 2018 Oct 12; 2018.
    View in: PubMed
    Score: 0.011
  46. Comparison of Dual ?-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. J Infect. 2018 11; 77(5):398-404.
    View in: PubMed
    Score: 0.011
  47. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018 05; 41(5):524-531.
    View in: PubMed
    Score: 0.011
  48. Impact of Abandoned Leads on Cardiovascular Implantable Electronic?Device Infections: A?Propensity Matched Analysis of MEDIC (Multicenter?Electrophysiologic Device Infection?Cohort). JACC Clin Electrophysiol. 2018 02; 4(2):201-208.
    View in: PubMed
    Score: 0.010
  49. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50(1):117-124.
    View in: PubMed
    Score: 0.010
  50. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 01; 64(11):1516-1521.
    View in: PubMed
    Score: 0.010
  51. Antibacterial Envelope Is Associated With?Low Infection Rates After Implantable Cardioverter-Defibrillator and?Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol. 2017 10; 3(10):1158-1167.
    View in: PubMed
    Score: 0.010
  52. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.010
  53. In-office insertion of a miniaturized insertable cardiac monitor: Results from the Reveal LINQ In-Office 2 randomized study. Heart Rhythm. 2017 02; 14(2):218-224.
    View in: PubMed
    Score: 0.010
  54. Prevalence of Enterococcus faecalis mediated UTI and its current antimicrobial susceptibility pattern in Lahore, Pakistan. J Pak Med Assoc. 2016 10; 66(10):1232-1236.
    View in: PubMed
    Score: 0.010
  55. Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves. Circ Arrhythm Electrophysiol. 2016 09; 9(9).
    View in: PubMed
    Score: 0.010
  56. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39(6):522-30.
    View in: PubMed
    Score: 0.009
  57. Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis (Lond). 2016; 48(5):373-8.
    View in: PubMed
    Score: 0.009
  58. Infective Endocarditis Involving the Pulmonary Valve. Am J Cardiol. 2015 Dec 15; 116(12):1928-31.
    View in: PubMed
    Score: 0.009
  59. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015 Oct; 170(4):830-6.
    View in: PubMed
    Score: 0.009
  60. Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association's Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015 Jul; 90(7):874-81.
    View in: PubMed
    Score: 0.009
  61. Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci. Clin Infect Dis. 2015 Aug 15; 61(4):623-5.
    View in: PubMed
    Score: 0.009
  62. Characteristics, management and outcomes of critically ill patients who are 80 years and older: a retrospective comparative cohort study. BMC Anesthesiol. 2014; 14:126.
    View in: PubMed
    Score: 0.009
  63. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses. 2014 Nov; 57(11):687-98.
    View in: PubMed
    Score: 0.008
  64. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014 Jun; 7(6):541-9.
    View in: PubMed
    Score: 0.008
  65. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014 Aug; 37(8):955-62.
    View in: PubMed
    Score: 0.008
  66. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013 Nov; 57(10):1438-48.
    View in: PubMed
    Score: 0.008
  67. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111(6):874-9.
    View in: PubMed
    Score: 0.007
  68. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15(2):227-35.
    View in: PubMed
    Score: 0.007
  69. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9.
    View in: PubMed
    Score: 0.007
  70. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14; 59(7):681-7.
    View in: PubMed
    Score: 0.007
  71. Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012 Mar; 35(3):269-74.
    View in: PubMed
    Score: 0.007
  72. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8(11):1678-85.
    View in: PubMed
    Score: 0.007
  73. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34(4):450-9.
    View in: PubMed
    Score: 0.006
  74. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.006
  75. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):639-45.
    View in: PubMed
    Score: 0.006
  76. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13.
    View in: PubMed
    Score: 0.006
  77. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
    View in: PubMed
    Score: 0.005
  78. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6.
    View in: PubMed
    Score: 0.005
  79. Corynebacterium jeikeium prosthetic joint infection: case report and literature review. Scand J Infect Dis. 2005; 37(2):151-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.